Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.65 |
| ▸ | MAOB | P27338 | 1/20 | 0.65 |
| ▸ | DRD2 | P14416 | 11/20 | 0.50 |
| ▸ | DRD1 | P21728 | 11/20 | 0.50 |
| ▸ | DRD5 | P21918 | 9/20 | 0.50 |
| ▸ | DRD3 | P35462 | 9/20 | 0.50 |
| ▸ | DRD4 | P21917 | 8/20 | 0.50 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30578750 | 1.00 | MAOA (0.65) | MAOAMAOBDRD2DRD1DRD5 | |
| SCHEMBL14041086 | 0.91 | MAOA (0.53) | MAOAMAOBDRD2DRD1DRD5 | |
| SCHEMBL30534978 | 0.90 | ESR2 (0.52) | MAOAMAOBDRD2DRD1DRD5 | |
| SCHEMBL3274879 | 0.90 | ESR2 (0.52) | MAOAMAOBDRD2DRD1DRD5 | |
| SCHEMBL2530756 | 0.89 | MAOA (0.65) | MAOAMAOBDRD2DRD1DRD5 | |
| SCHEMBL8168164 | 0.86 | MAPKAPK2 (0.47) | MAOAMAOBDRD2DRD1DRD5 | |
| Xanthene SCHEMBL27661782 | 0.82 | MAOA (0.74) | MAOAMAOBDRD2DRD1DRD5 | |
| Xanthene SCHEMBL3275202 | 0.82 | MAOA (0.74) | MAOAMAOBDRD2DRD1DRD5 | |
| SCHEMBL9455528 | 0.81 | MAOA (0.81) | MAOAMAOBMAPKAPK2ACSL1 | |
| Xanthene SCHEMBL29378346 | 0.81 | MAOA (1.00) | MAOAMAOBMAPKAPK2ACSL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011253-A | Sieber resin and preparation method and application thereof | 江苏海普功能材料有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-119350285-A | Anthracene skeleton compound and photoinitiator application thereof | 湖北兴福电子材料股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119350286-A | A series of multi-benzene ring photoinitiators and photoinitiator application thereof | 湖北兴福电子材料股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-116803999-A | Preparation method of 3-hydroxy-9H-xanthen-9-one | 安徽昊帆生物有限公司 | 2023-09-26 | — | — | CN | disclosed |
| US-20230159484-A1 | FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS | DYOMICS GMBH (DE) | 2023-05-25 | — | — | US | disclosed |
| EP-3144315-B1 | ENZYME-SPECIFIC FLUORESCENT COMPOUND CAPABLE OF BEING RETAINED IN CELLS | UNIV TOKYO (JP) | 2022-07-06 | — | — | EP | disclosed |
| CN-113473860-A | 1, 3, 4-oxadiazoles and derivatives thereof as novel antifungal agents | 拜耳公司 | 2021-10-01 | — | — | CN | disclosed |
| CN-106459125-B | The Intracellular retention fluorescent chemicals of enzyme spcificity | 国立大学法人东京大学 | 2019-05-07 | — | — | CN | disclosed |
| CN-109311980-A | G protein-coupled receptor (GPCR) modulation by emilienone (IMIPRIDONES) | 昂克希尔迪克斯有限公司 | 2019-02-05 | — | — | CN | disclosed |
| CN-104263816-B | Double label method for measuring cell Proliferation | 生命技术公司 | 2018-10-19 | — | — | CN | disclosed |
| CN-103735682-B | A kind of medicine that is used for the treatment of allergic dermatitis and preparation method thereof | ZHOU WENWU (CN) | 2016-05-18 | — | — | CN | disclosed |
| CN-103735682-A | Drug for treating allergic dermatitis and preparation method thereof | ZHOU WENWU | 2014-04-23 | — | — | CN | disclosed |
| WO-2008021926-A2 | MODULATORS OF GLUCOCORTICOID RECEPTOR, AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-02-21 | — | — | WO | disclosed |
| EP-1119554-A4 | XANTHAN-ESTER AND ACRIDAN SUBSTRATES FOR HORSERADISH PEROXIDASE | TROPIX INC (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1119554-A1 | XANTHAN-ESTER AND ACRIDAN SUBSTRATES FOR HORSERADISH PEROXIDASE | TROPIX, INC. (US) | 2001-08-01 | — | — | EP | disclosed |
| US-6162610-A | Xanthan-ester and acridan substrates for horseradish peroxidase | TROPIX, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| WO-2000015618-A1 | XANTHAN-ESTER AND ACRIDAN SUBSTRATES FOR HORSERADISH PEROXIDASE | TROPIX, INC. (US) | 2000-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159484-A1 | FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS | SUN2, IK, BRD7 | MAOA 4200/4885MAOB 3073/4885DRD2 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.